Literature DB >> 15158607

Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation.

Lesley Devine1, Michael E Hodsdon, Mark A Daniels, Stephen C Jameson, Paula B Kavathas.   

Abstract

MHC class I tetramers are widely used, usually in combination with an antibody to CD8, to detect antigen specific T cells. Some anti-CD8alpha antibodies block the interaction of murine MHC class I tetramers with CD8 T cells, while others such as 53.6.7, enhance. To understand the molecular basis for this effect, we mapped the epitope for the enhancing antibody 53.6.7 and three other blocking antibodies using a panel of murine CD8alpha (Lyt-2) mutants expressed on COS-7 transfectants. Mutations in residues that contact MHC class I affected binding of the blocking antibodies. In contrast, antibody 53.6.7 was affected by a mutation in the residue T81A located on the D-E loop. In the cocrystal of CD8alphaalpha with MHC class I, two different complexes (A and B) were observed, indicating the existence of different CD8 conformations. The T81 residue does not make contact with MHC class I in either complex, however, neighboring residues in the D-E loop make very different contacts in the two different complexes. The most likely explanation for antibody enhancement of tetramer bindings is that binding of 53.6.7 to CD8alphabeta stabilizes a conformation with a higher affinity for interaction with MHC class I and suggests that the CD8 binding site is flexible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158607     DOI: 10.1016/j.imlet.2004.02.002

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

2.  Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.

Authors:  Ralf-Holger Voss; Jürgen Kuball; Renate Engel; Philippe Guillaume; Pedro Romero; Christoph Huber; Matthias Theobald
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  A role for CD8 in the developmental tuning of antigen recognition and CD3 conformational change.

Authors:  Diana Gil; Adam G Schrum; Mark A Daniels; Ed Palmer
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

4.  Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination.

Authors:  Ning Jiang; Jun Huang; Lindsay J Edwards; Baoyu Liu; Yan Zhang; Carrie D Beal; Brian D Evavold; Cheng Zhu
Journal:  Immunity       Date:  2011-01-20       Impact factor: 31.745

5.  Antibody to varicella-zoster virus immediate-early protein 62 augments allodynia in zoster via brain-derived neurotrophic factor.

Authors:  Yuka Hama; Kimiyasu Shiraki; Yoshihiro Yoshida; Atsushi Maruyama; Makoto Yasuda; Masaaki Tsuda; Mariko Honda; Michiaki Takahashi; Hiroshi Higuchi; Ichiro Takasaki; Tohru Daikoku; Tadaharu Tsumoto
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.

Authors:  D A Shore; H Issafras; E Landais; L Teyton; I A Wilson
Journal:  J Mol Biol       Date:  2008-10-07       Impact factor: 5.469

7.  Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells.

Authors:  Eric W Cross; Trevor J Blain; Divij Mathew; Ross M Kedl
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

8.  A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.

Authors:  Xiangshu Wen; Seil Kim; Ran Xiong; Michelle Li; Agnieszka Lawrenczyk; Xue Huang; Si-Yi Chen; Ping Rao; Gurdyal S Besra; Paolo Dellabona; Giulia Casorati; Steven A Porcelli; Omid Akbari; Mark A Exley; Weiming Yuan
Journal:  J Immunol       Date:  2015-07-08       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.